Donald Hooker
Stock Analyst at Keybanc
(2.50)
# 2,323
Out of 5,152 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $5.12 | +1,853.13% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $181.32 | +115.09% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $203.98 | -16.66% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $178.50 | +62.46% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $12.08 | +504.30% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $3.54 | +916.95% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $5.61 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $196.06 | +80.05% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $79.96 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $78.79 | +6.61% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.40 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $275.92 | -38.39% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $110.60 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $0.85 | +5,309.22% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $469.38 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $5.12
Upside: +1,853.13%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $181.32
Upside: +115.09%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $203.98
Upside: -16.66%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $178.50
Upside: +62.46%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $12.08
Upside: +504.30%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $3.54
Upside: +916.95%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $5.61
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $196.06
Upside: +80.05%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $79.96
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $78.79
Upside: +6.61%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $3.40
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $275.92
Upside: -38.39%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $110.60
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $0.85
Upside: +5,309.22%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $469.38
Upside: -